Skip to content

Multimodality Treatment Including Curative Resection of Advanced NSCLC

Multimodality Treatment Including Curative Resection of Advanced Stage Non-small Cell Lung Cancer - an Explorative, Retrospective Pilot Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04455984
Enrollment
190
Registered
2020-07-02
Start date
2017-05-01
Completion date
2020-08-01
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Non-small-cell Lung Cancer

Brief summary

This study retrospectively evaluates clinical parameters and outcome of patients with advanced stage non-small cell lung cancer treated with neoadjuvant therapy followed by curative-intent surgery at the Divison of Thoracic Surgery at the Medical University of Vienna

Detailed description

This study will be undertaken as a retrospective cohort study at Devision of Thoracic Surgery, Medical University of Vienna. All patients with non-small-cell lung cancer, who received an induction chemo- or chemoradiotherapy followed by surgery in a curative intention at the Devision of Thoracic Surgery, Medical University, will be included. The aim of this study is to evaluate peri- and postoperative clinical parameters and short- and long-term outcomes in patients.

Interventions

Retrospective data analysis

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with advanced NSCLC and multimodality treatment including curative-intent resection

Exclusion criteria

* Patients with early stage NSCLC * Patients with advanced NSCLC without multimodality treatment * Patients without curative resection

Design outcomes

Primary

MeasureTime frameDescription
Overall survival18 years* Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery * Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery * Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery

Countries

Austria

Contacts

Primary ContactKatharina Sinn, MD
katharina.sinn@meduniwien.ac.at004314040056440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026